FORM OF PRIVATE PLACEMENT PURCHASE AGREEMENTPrivate Placement Purchase Agreement • January 20th, 2017 • Amarin Corp Plc\uk • Pharmaceutical preparations
(the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (the “Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is acquiring Purchased Notes (as defined below) hereunder, a “Purchaser”), enters into this Private Placement Purchase Agreement (the “Agreement”) with (a) Corsicanto II Designated Activity Company, a designated activity company incorporated under the laws of Ireland (the “Company”) and the wholly owned subsidiary of Amarin Corporation plc, a public limited company incorporated under the laws of England and Wales (the “Guarantor”) and (b) the Guarantor, on January 20, 2017 whereby the Purchaser will purchase (the “Purchase”) the Company’s 3.50% Convertible Senior Notes due 2047, which are guaranteed by the Guarantor (the “Notes”), that will be issued pursuant to the provisions of an Indenture to be dated as of the Closing Date (as defined herein) (the “Indent
